7642-58-2 ((7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one,(7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one)

CAS号:
7642-58-2
中文名称:
(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
英文名称:
(7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
分子式:
C20H30O2
分子量:
302.451006412506

(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one(7642-58-2)名称与标识符

名称

中文别名:
(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;
英文别名:
(7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one;CHEMBL359619;7alpha-Methyltestosterone;U 14103;AC1L6LCQ;7a-methyl-testosterone;Isomer 201;CHEMBL359619; 7alpha-Methyltestosterone; U 14103; AC1L6LCQ; 7a-methyl-testosterone; Isomer 201;;NSC63577;7Alpha-Methyl-Testosterone;Androst-4-en-3-one, 17-hydroxy-7-methyl-, (7-alpha,17-beta)-;Androst-4-en-3-one, 17-hydroxy-7-methyl-, (7.alpha.,17.beta.)-;Q27115881;NSC-63577;UNII-K76V9O14LF;7-alpha-Methyltestosterone;SCHEMBL4916351;17beta-Hydroxy-7alpha-methylandrost-4-en-3-one;7642-58-2;7.alpha.-Methyltestosterone;Androst-4-en-3-one, 17-hydroxy-7-methyl-, (7alpha,17beta)-;BDBM50423527;CHEBI:34183;Testosterone, 7.alpha.-methyl-;7-.alpha.-methyltestosterone;U-14103;17-beta-hydroxy-7-alpha-methyl-androst-4-en-3-one;DTXSID30227248;17beta-hydroxy-7alpha-methyl-4-androsten -3-one;Androst-4-en-3-one, 17beta-hydroxy-7alpha-methyl-;Androst-4-en-3-one, 17.beta.-hydroxy-7.alpha.-methyl-;17-.beta.-hydroxy-7-.alpha.-methyl-androst-4-en-3-one;NSC 63577;K76V9O14LF;Testosterone, 7-alpha-methyl-;

标识符

InChIKey:
HZWZHWTZLZZBFF-UQYBFTDGSA-N
Inchi:
1S/C20H30O2/c1-12-10-13-11-14(21)6-8-19(13,2)16-7-9-20(3)15(18(12)16)4-5-17(20)22/h11-12,15-18,22H,4-10H2,1-3H3/t12-,15+,16+,17+,18+,19+,20+/m1/s1
SMILES:
O[C@H]1CC[C@@H]2[C@]1(C)CC[C@@H]1[C@@]3(C)CCC(C=C3C[C@@H](C)[C@@H]21)=O

(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one(7642-58-2)物化性质

实验特性

  • PSA : 37.3

计算特性

  • 精确分子量 : 302.2247
  • 氢键供体数量 : 1
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 0
  • 同位素质量 : 302.224580195g/mol
  • 重原子数量 : 22
  • 复杂度 : 536
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 7
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.6
  • 拓扑分子极性表面积 : 37.3Ų

(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one(7642-58-2)相关文献